CITI Training Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Master CITI Training with our comprehensive practice exam. Boost your research skills, ensure compliance, and excel in your field. Start now for success!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

How long does the FDA have to review IND submissions?

60 days
30 days
90 days
45 days

The correct answer is: 30 days

The FDA typically has 30 days to review IND submissions. This allows them enough time to thoroughly evaluate the submission and make any necessary recommendations or requests for additional information. Option A (60 days) and C (90 days) are incorrect because they provide longer time frames than the standard 30 days. Option D (45 days) is incorrect because it provides a slightly longer time frame than the standard 30 days. However, the most accurate time frame for FDA review of IND submissions is 30 days.